eXoZymes lasse.g@exozymes.com https://exozymes.twentythree.com en-us Visualplatform http://blogs.law.harvard.edu/tech/rss eXoZymes episodic no https://exozymes.twentythree.com/files/rv0.0/sitelogo.gif https://exozymes.twentythree.com http://exozymes.twentythree.com/introducing-our-new-cco-damien <p><p>Our new Chief Commercial Officer, Damien Perriman, brings more than two decades of experience in successfully commercializing several biotechnologies, across areas such as nutrition, personal care, plastics, textiles, fragrances, performance fuels, and specialty chemicals. Before joining eXoZymes, Perriman most recently has served leading commercial roles at both Genomatica (Geno) and Gevo, while also serving as Chairman of the Board of Danish biotechnology startup Cellugy.</p></p><p><a href="http://exozymes.twentythree.com/introducing-our-new-cco-damien"><img src="http://exozymes.twentythree.com/64968579/111508926/95dc8ad576b503a2253bbe77c6fafd5a/standard/download-21-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/111508926 Wed, 02 Apr 2025 22:43:18 GMT Introducing our new CCO: Damien Perriman Our new Chief Commercial Officer, Damien Perriman, brings more than two decades of experience in successfully commercializing several biotechnologies, across areas such as nutrition, personal care, plastics, textiles, fragrances, performance fuels, and specialty chemicals. Before joining eXoZymes, Perriman most recently has served leading commercial roles at both Genomatica (Geno) and Gevo, while also serving as Chairman of the Board of Danish biotechnology startup Cellugy. Our new Chief Commercial Officer, Damien Perriman, brings more than two decades of experience in successfully commercializing several biotechnologies, across areas such as nutrition, personal care, plastics, textiles, fragrances, performance... eXoZymes 03:37 <p><p>Our new Chief Commercial Officer, Damien Perriman, brings more than two decades of experience in successfully commercializing several biotechnologies, across areas such as nutrition, personal care, plastics, textiles, fragrances, performance fuels, and specialty chemicals. Before joining eXoZymes, Perriman most recently has served leading commercial roles at both Genomatica (Geno) and Gevo, while also serving as Chairman of the Board of Danish biotechnology startup Cellugy.</p></p><p><a href="http://exozymes.twentythree.com/introducing-our-new-cco-damien"><img src="http://exozymes.twentythree.com/64968579/111508926/95dc8ad576b503a2253bbe77c6fafd5a/standard/download-21-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/fox-business-interview-with-ceo <p><p></p> </p><p><a href="http://exozymes.twentythree.com/fox-business-interview-with-ceo"><img src="http://exozymes.twentythree.com/64968566/110849024/d61ced71de6ce1f26413933e66c3d488/standard/download-29-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/110849024 Thu, 13 Mar 2025 21:58:14 GMT Fox Business interview with CEO Michael Heltzen eXoZymes 07:38 <p><p></p> </p><p><a href="http://exozymes.twentythree.com/fox-business-interview-with-ceo"><img src="http://exozymes.twentythree.com/64968566/110849024/d61ced71de6ce1f26413933e66c3d488/standard/download-29-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/how-exozymes-started-interviews <p><p>Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.</p> </p><p><a href="http://exozymes.twentythree.com/how-exozymes-started-interviews"><img src="http://exozymes.twentythree.com/64968570/110628808/cef80cbbdf8b686eb04f59b8bdd8af3e/standard/download-10-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/110628808 Mon, 10 Mar 2025 20:40:01 GMT How eXoZymes started: Interviews with Tyler Korman and Paul Opgenorth Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way. Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as... eXoZymes 06:54 <p><p>Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.</p> </p><p><a href="http://exozymes.twentythree.com/how-exozymes-started-interviews"><img src="http://exozymes.twentythree.com/64968570/110628808/cef80cbbdf8b686eb04f59b8bdd8af3e/standard/download-10-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/nasdaq-tower-an-hour-of-exozymes <p><p>An hour of eXoZymes’ employees and messages as displayed on the Nasdaq tower in New York City on Feb 19, 2025.</p> </p><p><a href="http://exozymes.twentythree.com/nasdaq-tower-an-hour-of-exozymes"><img src="http://exozymes.twentythree.com/64968560/110203031/e458bfa93fb74923d8af5356466d1a22/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/110203031 Mon, 24 Feb 2025 20:54:30 GMT Nasdaq tower: An hour of eXoZymes An hour of eXoZymes’ employees and messages as displayed on the Nasdaq tower in New York City on Feb 19, 2025. An hour of eXoZymes’ employees and messages as displayed on the Nasdaq tower in New York City on Feb 19, 2025. eXoZymes 51:19 <p><p>An hour of eXoZymes’ employees and messages as displayed on the Nasdaq tower in New York City on Feb 19, 2025.</p> </p><p><a href="http://exozymes.twentythree.com/nasdaq-tower-an-hour-of-exozymes"><img src="http://exozymes.twentythree.com/64968560/110203031/e458bfa93fb74923d8af5356466d1a22/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/cnbc-closing-bell-footage-from-feb <p><p>Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC.</p> <p></p> <p>Credit: CNBC &amp; Nasdaq, Inc.</p> </p><p><a href="http://exozymes.twentythree.com/cnbc-closing-bell-footage-from-feb"><img src="http://exozymes.twentythree.com/64968578/110153296/82f04207ce89b6720d4da6086e276a11/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/110153296 Fri, 21 Feb 2025 18:33:16 GMT CNBC closing bell footage from Feb 19, 2025 Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC. Credit: CNBC Nasdaq, Inc. Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC. Credit: CNBC Nasdaq, Inc. eXoZymes 00:34 <p><p>Part of the coverage of eXoZymes’ closing bell ceremony on Feb 19, 2025 from CNBC.</p> <p></p> <p>Credit: CNBC &amp; Nasdaq, Inc.</p> </p><p><a href="http://exozymes.twentythree.com/cnbc-closing-bell-footage-from-feb"><img src="http://exozymes.twentythree.com/64968578/110153296/82f04207ce89b6720d4da6086e276a11/standard/download-11-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/nasdaq-tower-enzymes-x-ai-exozymes <p><p>Captured on Feb 19, when the eXoZymes team rang the closing bell at Nasdaq in New York.</p> <p></p> <p>Credit: Nasdaq, Inc.</p> </p><p><a href="http://exozymes.twentythree.com/nasdaq-tower-enzymes-x-ai-exozymes"><img src="http://exozymes.twentythree.com/64968580/110129871/ec214568dc1c1553806ab556abd35ca7/standard/download-10-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/110129871 Thu, 20 Feb 2025 17:22:46 GMT Nasdaq tower: enzymes x AI = exozymes Captured on Feb 19, when the eXoZymes team rang the closing bell at Nasdaq in New York. Credit: Nasdaq, Inc. Captured on Feb 19, when the eXoZymes team rang the closing bell at Nasdaq in New York. Credit: Nasdaq, Inc. eXoZymes 00:15 <p><p>Captured on Feb 19, when the eXoZymes team rang the closing bell at Nasdaq in New York.</p> <p></p> <p>Credit: Nasdaq, Inc.</p> </p><p><a href="http://exozymes.twentythree.com/nasdaq-tower-enzymes-x-ai-exozymes"><img src="http://exozymes.twentythree.com/64968580/110129871/ec214568dc1c1553806ab556abd35ca7/standard/download-10-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/the-story-of-exozymes-interview <p><p>Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.</p></p><p><a href="http://exozymes.twentythree.com/the-story-of-exozymes-interview"><img src="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/standard/download-45-thumbnail.jpg" width="75" height=""/></a></p> http://exozymes.twentythree.com/photo/100951904 Wed, 22 May 2024 16:33:18 GMT The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way. Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as... eXoZymes 06:56 <p><p>Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.</p></p><p><a href="http://exozymes.twentythree.com/the-story-of-exozymes-interview"><img src="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/standard/download-45-thumbnail.jpg" width="75" height=""/></a></p> cannabinoids founder interview invizyne isobutanol jim bowie paul opgenorth SAF sustainable aviation fuel tyler korman